78
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline

, , &
Pages 2097-2104 | Accepted 21 Jun 2010, Published online: 20 Jul 2010

References

  • Kelman L. Pain characteristics of the acute migraine attack. Headache 2006;46:942-53
  • Adoukonou T, Houinato D, Kankouan J, et al. Migraine among university students in Cotonou (Benin). Headache 2009;49:887-93
  • Dahlof C, Linde M. One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia 2001;21:664-71
  • Kallela M, Wessman M, Farkkila M, et al. Clinical characteristics of migraine in a population-based twin sample: similarities and differences between migraine with and without aura. Cephalalgia 1999;19:151-8
  • Wober-Bingol C, Wober C, Karwautz A, et al. Clinical features of migraine: a cross-sectional study in patients aged three to sixty-nine. Cephalalgia 2004;24:12-17
  • Silberstein S. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee for the American Academy of Neurology. Neurology 2000;55:754-62
  • Matchar DB, Young WB, Rosenberg JH, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. St. Paul, MN: US Headache Consortium (American Academy of Neurology, American Academy of Family Physicians, American Headache Society, American College of Emergency Physicians, American College of Physicians [American Society of Internal Medicine], American Osteopathic Association, National Headache Foundation); 2000
  • Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur J Neurol 2006;13:560-72
  • Diener HC, Gendolla A, Gebert I, et al. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Headache 2005;45:874-82
  • Goldstein J, Tiseo PT, Albert KS, et al. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. Headache 2006;46:1142-50
  • Poolsup N, Leelasangaluk V, Jittangtrong J, et al. Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials. J Clin Pharm Ther 2005;30:521-32
  • Buchan P, Keywood C, Wade A, et al. Clinical pharmacokinetics of frovatriptan. Headache 2002;42:S54-62
  • Geraud G, Keywood C, Senard JM. Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Headache 2003;43:376-88
  • Diener HC, Pfaffenrath V. Efficacy and tolerability of frovatriptan in practice – results of two postmarketing surveillance studies with 16,737 migraine patients. Nervenheilkunde 2007;26:180-5
  • Murtaza M, Kisat M, Daniel H, et al. Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data. PLoS One 2009;4:e5827
  • Adeney KL, Flores JL, Perez JC, et al. Prevalence and correlates of migraine among women attending a prenatal care clinic in Lima, Peru. Cephalalgia 2006;26:1089-96
  • Dzoljic E, Sipetic S, Vlajinac H, et al. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 2002;42:185-93
  • Granella F, Sances G, Pucci E, et al. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000;20:701-7
  • Couturier EG, Bomhof MA, Neven AK, et al. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003;23:302-8
  • Granella F, Sances G, Allais G, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004;24:707-16
  • MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004;63:351-3
  • Spierings EL, Keywood C. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study. Pain Med 2009;10:633-8
  • Chia YC, Lim SH, Wang SJ, et al. Efficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugs. Headache 2003;43:984-90
  • Diener HC, Gendolla A. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany. Curr Med Res Opin 2005;21:S18-24
  • Cady RK, Banks J, Jones BA, et al. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination. Curr Med Res Opin 2009;25:2711-21
  • Wallasch TM. Frovatriptan in the practice of office-based neurologists/pain therapists: results of postmarketing surveillance study ALADIN. Adv Ther 2010;27:56-62; Epub Feb 6
  • Dodick DW. Triptan nonresponder studies: implications for clinical practice. Headache 2005;45:156-62
  • Farkkila M, Olesen J, Dahlof C, et al. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 2003;23:463-71
  • Stark S, Spierings EL, McNeal S, et al. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan. Headache 2000;40:513-20
  • Eich E, Reeves JL, Jaeger B, et al. Memory for pain: relation between past and present pain intensity. Pain 1985;23:375-80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.